Drug targets: single-cell transcriptomics hastens unbiased discovery

Area of Science:

• Neuroscience
• Pharmacology
• Genomics
• Molecular Biology

Background:

• Drug discovery in neuro- and psychopharmacology faces challenges due to a limited number of identified drug targets.
• Existing methods may fail to detect low-abundance targets like specific receptors and channels in neurons.
• The scarcity of validated drug targets hinders the development of new therapeutics for neurological and psychiatric disorders.

Purpose of the Study:

• To highlight the potential of Next-Generation sequencing based single-cell transcriptomics (SBSCT) for identifying novel drug targets.
• To demonstrate SBSCT's capability in revealing the complete receptor repertoire of individual neurons.
• To advocate for SBSCT as a superior method for drug target discovery compared to other single-cell profiling techniques.

Main Methods:

• Utilized sequencing based single-cell transcriptomics (SBSCT) to analyze individual neurons.
• Identified hundreds of different receptors and channels within single neurons.
• Compared the efficacy of SBSCT with other single-cell profiling methods for target identification.

Main Results:

• SBSCT successfully identified a wide array of receptors and channels in individual neurons.
• The method accurately detected low-abundance mRNAs encoding receptors, avoiding signal dilution issues common in pooled-cell analyses.
• SBSCT demonstrated potential for identifying orphan receptors and providing evidence for receptor heterodimers.

Conclusions:

• SBSCT is a powerful and unbiased tool for discovering novel drug targets in neuro- and psychopharmacology.
• The technique enables the identification of previously overlooked receptors on key neurons that may have therapeutic value.
• SBSCT offers a significant advancement for identifying targets crucial for developing new neurological and psychiatric medications.